Article: Advanced Viral Research Corp. Receives $50 Million Equity Line of Credit.

- Financing for Planned IND Applications to the FDA

For 'Product R' and Working Capital -

YONKERS, N.Y., Feb. 15 /PRNewswire/ --

Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) today announced that it has signed a revised financing contract for a $50 million equity line of credit. In addition, the registration statement covering the resale of the shares issuable under this financing contract was declared effective by the United States Securities and Exchange Commission (SEC). Under the financing contract, subject to certain conditions, a private investor has committed up to $50 million to purchase shares of Advanced Viral Research ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!